Ignite Creation Date:
2024-05-06 @ 1:40 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04088110
Status:
UNKNOWN
Last Update Posted:
2019-09-12
First Post:
2019-09-11
Brief Title:
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
Sponsor:
Fuzhou General Hospital
Organization:
Fuzhou General Hospital
Organization Data
Organization:
Fuzhou General Hospital
Class:
OTHER
Study ID:
Arise-FJ-B102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fuzhou General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None